Axonics

Axonics Stock-Based Compensation

The Stock-Based Compensation (SBC) of Axonics (AXNX) as of Nov 19, 2026 is 44.54 M USD. In the previous year, Stock-Based Compensation (SBC) was 32.02 M USD — a change of 39.10% (higher).

Stock-Based Compensation

44.54 MUSD

YoY

39.10%

Last updated:

Stock-Based Compensation (SBC) of Axonics is 2023 44.54 M USD. Stock-Based Compensation (SBC) of Axonics was 2022 32.02 M USD. It decreases by 39.10% higher compared to the previous year.

The Axonics Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2016
321,476.00 USD
Jan 1, 2017
461,230.00 USD
Jan 1, 2018
606,000.00 USD
Jan 1, 2019
8.72 M USD
Jan 1, 2020
15.10 M USD
Jan 1, 2021
25.16 M USD
Jan 1, 2022
32.02 M USD
Jan 1, 2023
44.54 M USD
The Axonics Stock-Based Compensation history
YEARStock-Based CompensationYoY
44.54 MUSD+39.10%
32.02 MUSD+27.24%
25.16 MUSD+66.70%
15.10 MUSD+73.11%
8.72 MUSD+1,338.94%
606,000.00USD+31.39%
461,230.00USD+43.47%
321,476.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axonics Stock analysis

What does Axonics do? Axonics Modulation Technologies Inc. is a medical device company that was founded in 2013 and is headquartered in Irvine, California. The company specializes in the development and marketing of innovative therapy devices for the treatment of bladder dysfunction and bowel diseases. Axonics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axonics stock

Stock-Based Compensation (SBC) of Axonics is 44.54 M USD in 2023.

Stock-Based Compensation (SBC) of Axonics changed from 32.02 M USD to 44.54 M USD, representing a 39.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Axonics since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Axonics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Axonics

All Key Metrics — Axonics